Generation of antibodies and assays for transforming growth factor alpha.

[1]  I. Figari,et al.  The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. , 1990, Journal of immunology.

[2]  R. Derynck,et al.  Transforming growth factor‐α , 1990, Molecular reproduction and development.

[3]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[4]  J. Dasch,et al.  Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. , 1989, Journal of immunology.

[5]  R. Derynck,et al.  Transmembrane TGF-α precursors activate EGF/TGF-α receptors , 1989, Cell.

[6]  L. Bonewald,et al.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. , 1989, Biochemical and biophysical research communications.

[7]  J. Massagué,et al.  The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction , 1989, Cell.

[8]  M. Sporn,et al.  Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture , 1989 .

[9]  R. Derynck,et al.  A new type of transforming growth factor‐beta, TGF‐beta 3. , 1988, The EMBO journal.

[10]  M. Sporn,et al.  SEQUENCES OF INTEREST: Complementary Deoxyribonucleic Acid Cloning of a Novel Transforming Growth Factor-β Messenger Ribonucleic Acid from Chick Embryo Chondrocytes , 1988 .

[11]  I A Silver,et al.  Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. , 1988, Experimental cell research.

[12]  B. Haendler,et al.  Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family. , 1987, The EMBO journal.

[13]  A. Roberts,et al.  Membrane binding characteristics of two forms of transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[14]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[15]  L M Wakefield,et al.  Distribution and modulation of the cellular receptor for transforming growth factor-beta , 1987, The Journal of cell biology.

[16]  R. Derynck,et al.  Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursor , 1987, Cell.

[17]  C. Lambré,et al.  Lysosomal and cytosolic sialidases in rabbit alveolar macrophages: demonstration of increased lysosomal activity after in vivo activation with bacillus Calmette-Guerin. , 1987, Biochimica et biophysica acta.

[18]  T. Bringman,et al.  The purification of fully active recombinant transforming growth factor alpha produced in Escherichia coli. , 1986, The Journal of biological chemistry.

[19]  M. Sporn,et al.  A binding assay for the solubilized receptors of type beta transforming growth factor: adsorption and removal of free ligand by dextran-coated charcoal. , 1986, Analytical biochemistry.

[20]  M. Sporn,et al.  Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.

[21]  D. Lawrence,et al.  Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions , 1985 .

[22]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[23]  M. Sporn,et al.  Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. , 1984, The Journal of biological chemistry.

[24]  E. Chen,et al.  Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.

[25]  D. Scheidegger,et al.  Production of monoclonal antibodies: strategy and tactics. , 1980, Journal of immunological methods.

[26]  K. Rajewsky,et al.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. , 1979, Journal of immunology.

[27]  J. Goding.  Use of staphylococcal protein A as an immunological reagent. , 1978, Journal of immunological methods.

[28]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[29]  J. Pumphrey,et al.  Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. , 1972, Journal of the National Cancer Institute.

[30]  J. Thorell,et al.  Enzymatic iodination of polypeptides with 125I to high specific activity. , 1971, Biochimica et biophysica acta.

[31]  E. Engvall,et al.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. , 1971, Immunochemistry.

[32]  G. B. Pierce,et al.  ENZYME-LABELED ANTIBODIES FOR THE LIGHT AND ELECTRON MICROSCOPIC LOCALIZATION OF TISSUE ANTIGENS , 1967, The Journal of cell biology.

[33]  J. Littlefield.  Selection of Hybrids from Matings of Fibroblasts in vitro and Their Presumed Recombinants , 1964, Science.

[34]  D. Marquardt.  An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[35]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.